Capricor Therapeutics Inc (NASDAQ:CAPR)
| 2.77 Delayed Data As of 4:02pm ET |  -0.12 / -4.15%Today’s Change | 2.56 Today|||52-Week Range 8.40 | -5.46% Year-to-Date |
Latest CAPR News | Press Releases
No recent news for Capricor Therapeutics Inc.
Today’s Trading
| Previous close | 2.89 |
| Today’s open | 2.88 |
| Day’s range | 2.60 - 2.85 |
| Volume | 7,527 |
| Average volume (3 months) | 528,910 |
| Market cap | $70.0M |
Data as of 4:02pm ET, 01/24/2022
Growth & Valuation
| Earnings growth (last year) | +57.40% |
| Earnings growth (this year) | +9.09% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -69.13% |
| P/E ratio | NM |
| Price/Sales | 172.15 |
| Price/Book | 2.12 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ENTXEntera Bio Ltd | -0.10 | -4.13% |
| DMACDiaMedica Therapeuti... | -0.30 | -11.32% |
| ACRXAcelRx Pharmaceutica... | -0.02 | -3.97% |
| AGTCApplied Genetic Tech... | +0.03 | +1.91% |
Data as of 4:03pm ET, 01/24/2022
Financials
| Next reporting date | March 16, 2022 |
| EPS forecast (this quarter) | -$0.19 |
| Annual revenue (last year) | $310.3K |
| Annual profit (last year) | -$13.7M |
| Net profit margin | -4,401.94% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Beverly Hills, California |
Forecasts
